1.646.889.1200|info@lifescipublicrelations.com

Samumed CMO Hopes To Reach Drug Approvals Via The Wnt Pathway

//Samumed CMO Hopes To Reach Drug Approvals Via The Wnt Pathway

Samumed CMO Hopes To Reach Drug Approvals Via The Wnt Pathway

The clinical-stage biotech has diverse pipeline generated by its Wnt signalling pathway technology platform, and aims to get its first drug to market in 2020.

By | 2018-07-16T17:25:56-04:00 May 3rd, 2018|News|Comments Off on Samumed CMO Hopes To Reach Drug Approvals Via The Wnt Pathway

About the Author:

Related Posts

LifeSci Public Relations

LifeSci Public Relations LLC is a corporate communications and public relations firm helping clients engage their corporate audiences and achieve their business objectives via a broad array of traditional, social and digital media tools.